The global dosimetry market will create incremental dollar opportunities to the tune of US$ 4 Bn from 2019 to 2029. Research and development in cancer treatment and medical devices used for chemotherapy will generate continued sales for dosimetry products. Increases in the geriatric population segment of developed countries such as the US coupled with declining health conditions create lucrative opportunities for the dosimetry market. Omnipresent government investments in developing nuclear energy capabilities will further the demand for dosimeters during the forecast period.
“Growing emphasis on monitoring and propagating the health of hospital staff treating cancer patients will generate additional revenues for market players. Further, the uptake in residential chemotherapy furthers the demand for remote monitoring of radiation levels using dosimetry products.” finds a FMI analyst
For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3482
Dosimetry refers to a technique utilized to measure the dosage of medicines as well as the ionizing radiation received by an individual. In recent years, there is remarkable increase in cases of cardiovascular diseases, skin cancers, and other neurology-related diseases. Thus, the world is witnessing increased rate of installation of SPECT and PET scanners, which are utilized for the diagnosis of these diseases
Dosimetry market – Key Takeaways
- Personal electronic dosimeters hold more than 60% share of the total market revenues.
- Wearable dosimeter will account for an eminent revenue share among modality segments.
- Passive dosimeters maintain their hegemony holding a majority market value share.
- Industrial and medical end-uses will garner a lion’s share of 40% of the total market value.
- North America currently leads global sales.
- South Asia & Oceania present the most remunerative growth opportunities through 2029.
Dosimetry market – Key Driving Factors
- Emphasis on enhanced protection of medical professionals working in high radiation environments drives growth for dosimetry product manufacturers.
- Increase in consumer spending on cancer detection tests and treatments continue to bolster revenues for market players.
- Advancements in high-performance dosimetry coupled with reduction in product size propels the adoption of dosimetry in end-uses.
- Growing demand for residential care for cancer patients on the back of high disposable income of consumers will continue to generate revenues.
Dosimetry Market – Key Constraint
- Scrutiny of nuclear projects from non-profit organizations run by radiation affected patients poses mild constraint on the demand for dosimetry products for preventive healthcare checks.
Request the coronavirus impact analysis across industries and markets https://www.futuremarketinsights.com/covid19/rep-gb-3482
Calculating the Negative Impact of COVID-19
The pandemic has shifted focus on essential medical supplies such as ventilators, face masks, and sterilization equipment. This has a negative impact on the growth of the dosimetry market. As transportation of all non-essential healthcare products is suspended to contain the COVID-19 outbreak. Market players will witness an uptake in demand depending on how countries’ healthcare response fairs against novel coronavirus.
However, manufacturers are urged to contribute in any capacity they can. This means demand from cancer patients undergoing treatment should be catered to amid the pandemic. Manufacturers must then devise strategies to manufacture and deliver dosimeters to crucial cancer patients and healthcare institutions.
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/3482
Leveraging industry 4.0 technologies to enhance product performance, and production capacity are the most popular strategies among major players. Mergers and acquisitions are a commonplace occurrence in the dosimetry market. For instance, acquisition of Canberra Industries by Mirion Technologies was one of the biggest acquisitions in the history of the dosimetry market. Competition in dosimetry products is moving towards consolidation during the forecast period. Key players in the market are, but not limited to, Honeywell, Fisher Scientific Inc., Landauer, Inc. (Fortive), Mirion Technologies Inc., Fuji Electric Corporation of America, Polimaster Inc., JP Laboratories Inc., X-Z Lab Inc., Ludlum Measurements Inc., Laurus Systems Inc., Far West Technology Inc., and S.E. International Inc.
More About the Report
The FMI’s market research report of 300 pages offers comprehensive insights on the synthetic quartz market. The market is analyzed on the basis of product (personal electronic, self-reading, and processed dosimeters), modality (wearable (collar, chest, waist, wrist, and finger), and non-wearable), energy (active and passive), end-user (industrial, medical, oil & gas, defense & homeland security, mining, environmental, and others), across seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).
Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals, and Medical Devices Landscape
Ablation Devices Market: Find in-depth insights on the global ablation devices market with exhaustive segment-wide analysis, market statistics, key influencing factors, prominent players and critical developmental strategies adopted by them for a 10-year forecast period.
Preterm Birth Prevention and Management Market: FMI’s report on the global preterm birth prevention and management market offers a comprehensive commentary on the market poised for prolific growth during 2019-2029. The study covers comprehensive evaluation of key impacting forces, revenue sources, and market leaders in addition to essential market strategies.
Generic Injectable Market: Get a deep-dive analysis on the generic injectable market with crucial insights on growth levers, opportunities, restraints, regulatory policies, regional market forecast and key forte of market leaders.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com
Press Release Source: https://www.futuremarketinsights.com/press-release/dosimetry-market